查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448620

全球美容注射市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Aesthetic Injectables Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 276 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2032 年，全球美容注射劑市場的市場規模將從 2023 年的 143.6 億美元達到近 376.4 億美元，2024-2032 年研究期間的CAGR為 11.3%。

美容注射劑是指注射肉毒桿菌毒素 (Botox)、真皮填充劑或神經毒素等物質以增強臉部美觀的美容療程。這些注射劑用於減少皺紋、恢復體積和改善整體皮膚外觀。

市場動態

非侵入性整容手術需求的擴大、注射技術的進步以及對外觀改善的日益重視推動了美容注射劑市場的發展。美容注射劑，包括真皮填充劑和肉毒桿菌產品，為減少皺紋、臉部輪廓和皮膚年輕化提供微創解決方案。對無需手術干預即可獲得年輕自然效果的渴望推動了美容注射的流行。社群媒體的影響力、名人代言以及整容手術的接受度都有助於擴大消費者基礎。此外，更持久的配方和改進的安全性等技術創新也有助於市場成長。可支配收入的增加和社會對老齡化態度的變化進一步推動了對美容注射劑的需求，使其成為全球美容和化妝品行業不斷發展的格局中不可或缺的一部分。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球美容注射劑市場的各個細分市場進行了包容性評估。美容注射劑產業的成長和趨勢為本研究提供了整體方法。

市場區隔

美容注射市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按類型

  • 肉毒桿菌毒素（肉毒桿菌A、肉毒桿菌毒素B）
  • 真皮填充劑（產品（透明質酸、羥基磷灰石鈣、聚L-乳酸、聚甲基丙烯酸甲酯微球(Pmma)、膠原蛋白、脂肪填充劑、其他真皮填充劑）、應用（臉部提升、臉部矯正、減少皺紋、痤瘡疤痕、脂肪萎縮、豐唇、豐臀、豐胸、手部​​年輕化、陰莖增大、眼瞼整形、頸部和下巴提升、其他））

按性別

  • 女性
  • 男性

按年齡段

  • 15 - 30 次
  • 31 - 40
  • 41 - 50
  • 51 - 60
  • >60

按最終用戶

  • 醫院
  • 皮膚科診所
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲美容注射市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。美容注射劑市場的主要參與者包括艾伯維公司（Allergan Plc.）、Bio-Med Private Limited、Bioxis Pharmaceuticals、Cytophil, Inc.、Galderma SA、Ipsen SA、Laboratories Vivacy SAS、Merz Pharma GmbH & Co. KGaA。 、Mesoestetic、Sinclair Pharma（華東醫藥股份有限公司）、Suneva Medical, Inc.、Teoxane Laboratories。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：美容注射 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按性別分類的市場吸引力分析
    • 按年齡層別分類的市場吸引力分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球美容注射市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 肉毒桿菌毒素（肉毒桿菌A、肉毒桿菌毒素B）
  • 真皮填充劑（產品（透明質酸、羥基磷灰石鈣、聚L-乳酸、聚甲基丙烯酸甲酯微球(PMMA)、膠原蛋白、脂肪填充劑、其他真皮填充劑）、應用（臉部提升、臉部矯正、減少皺紋、痤瘡疤痕、脂肪萎縮、豐唇、豐臀、豐胸、手部​​年輕化、陰莖增大、眼瞼整形、頸部和下巴提升、其他））

第 6 章：全球美容注射市場分析：依性別

  • 按性別分類的概覽
  • 歷史和預測數據
  • 按性別分析
  • 女性
  • 男性

第 7 章：全球美容注射市場分析：依年齡層

  • 依年齡層別概覽
  • 歷史和預測數據
  • 按年齡層分析
  • 15 - 30 次
  • 31 - 40
  • 41 - 50
  • 51 - 60
  • >60

第 8 章：全球美容注射劑市場分析：依最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 醫院
  • 皮膚科診所
  • 其他

第 9 章：全球美容注射市場分析：按地理區域

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：美容注射公司的競爭格局

  • 美容注射劑市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • AbbVie Inc. (Allergan Plc.)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Med Private Limited
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bioxis Pharmaceuticals
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Cytophil Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Galderma SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Ipsen SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Laboratories Vivacy SAS
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merz Pharma GmbH & Co. KGaA.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Mesoestetic
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Sinclair Pharma (Huadong Medicine Co. Ltd.)
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Suneva Medical Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Teoxane Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112113721

The global demand for Aesthetic Injectables Market is presumed to reach the market size of nearly USD 37.64 Billion by 2032 from USD 14.36 Billion in 2023 with a CAGR of 11.3% under the study period 2024 - 2032.

Aesthetic injectables are cosmetic treatments involving the injection of substances like botulinum toxin (Botox), dermal fillers, or neurotoxins to enhance facial aesthetics. These injectables are used to reduce wrinkles, restore volume, and improve overall skin appearance.

MARKET DYNAMICS

The aesthetic injectables market is propelled by scaling demand for non-invasive cosmetic procedures, advancements in injectable technologies, and the increasing emphasis on appearance enhancement. Aesthetic injectables, including dermal fillers and botulinum toxin products, offer minimally invasive solutions for wrinkle reduction, facial contouring, and skin rejuvenation. The desire for youthful and natural-looking results without surgical intervention drives the popularity of aesthetic injectables. The social media influence, celebrity endorsements, and the acceptance of cosmetic procedures contribute to the expanding consumer base. Additionally, technological innovations, such as longer-lasting formulations and improved safety profiles, contribute to market growth. The rise in disposable income and the change in societal attitudes towards aging further fuel the demand for aesthetic injectables, making them integral to the evolving landscape of the global beauty and cosmetic industry.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of aesthetic injectables. The growth and trends of aesthetic injectables industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the aesthetic injectables market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Botulinum Toxin (Botulinum Toxin A, Botulinum Toxin B)
  • Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (Pmma), Collagen, Fat Fillers, Other Dermal Fillers), Application (Face Lift, Facial Correction, Wrinkles Reduction, Acne Scar, Lipoatrophy, Lip Enhancement, Hip Augmentation, Breast Enhancement, Hand Rejuvenation, Penis Enlargement, Blepharoplasty, Neck & Chin Lift, Other))

By Gender

  • Female
  • Male

By Age Group

  • 15 - 30
  • 31 - 40
  • 41 - 50
  • 51 - 60
  • >60

By End-User

  • Hospitals
  • Dermatology Clinics
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Aesthetic Injectables market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Aesthetic Injectables market include AbbVie Inc. (Allergan Plc.), Bio-Med Private Limited, Bioxis Pharmaceuticals, Cytophil, Inc., Galderma S.A., Ipsen SA, Laboratories Vivacy SAS, Merz Pharma GmbH & Co. KGaA., Mesoestetic, Sinclair Pharma (Huadong Medicine Co., Ltd.), Suneva Medical, Inc., Teoxane Laboratories. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . AESTHETIC INJECTABLES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Gender
    • 3.7.3 Market Attractiveness Analysis By Age Group
    • 3.7.4 Market Attractiveness Analysis By End-user
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Botulinum Toxin (Botulinum Toxin A, Botulinum Toxin B) Historic and Forecast Sales by Regions
  • 5.5 Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Collagen, Fat Fillers, Other Dermal Fillers), Application (Face Lift, Facial Correction, Wrinkles Reduction, Acne Scar, Lipoatrophy, Lip Enhancement, Hip Augmentation, Breast Enhancement, Hand Rejuvenation, Penis Enlargement, Blepharoplasty, Neck & Chin Lift, Other)) Historic and Forecast Sales by Regions

6 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY GENDER

  • 6.1 Overview by Gender
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Gender
  • 6.4 Female Historic and Forecast Sales by Regions
  • 6.5 Male Historic and Forecast Sales by Regions

7 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY AGE GROUP

  • 7.1 Overview by Age Group
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Age Group
  • 7.4 15 - 30 Historic and Forecast Sales by Regions
  • 7.5 31 - 40 Historic and Forecast Sales by Regions
  • 7.6 41 - 50 Historic and Forecast Sales by Regions
  • 7.7 51 - 60 Historic and Forecast Sales by Regions
  • 7.8 >60 Historic and Forecast Sales by Regions

8 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY END-USER

  • 8.1 Overview by End-user
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-user
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Dermatology Clinics Historic and Forecast Sales by Regions
  • 8.6 Other Historic and Forecast Sales by Regions

9 . GLOBAL AESTHETIC INJECTABLES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE AESTHETIC INJECTABLES COMPANIES

  • 10.1. Aesthetic Injectables Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF AESTHETIC INJECTABLES INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. AbbVie Inc. (Allergan Plc.)
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Bio-Med Private Limited
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Bioxis Pharmaceuticals
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Cytophil Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Galderma S.A.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Ipsen SA
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Laboratories Vivacy SAS
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Merz Pharma GmbH & Co. KGaA.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Mesoestetic
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Sinclair Pharma (Huadong Medicine Co. Ltd.)
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Suneva Medical Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Teoxane Laboratories
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Botulinum Toxin (Botulinum Toxin A, Botulinum Toxin B) Market Sales by Geography (USD MN)
  • Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Collagen, Fat Fillers, Other Dermal Fillers), Application (Face Lift, Facial Correction, Wrinkles Reduction, Acne Scar, Lipoatrophy, Lip Enhancement, Hip Augmentation, Breast Enhancement, Hand Rejuvenation, Penis Enlargement, Blepharoplasty, Neck & Chin Lift, Other)) Market Sales by Geography (USD MN)
  • Analysis Market by Gender (USD MN)
  • Female Market Sales by Geography (USD MN)
  • Male Market Sales by Geography (USD MN)
  • Analysis by Age Group (USD MN)
  • 15 - 30 Market Sales by Geography (USD MN)
  • 31 - 40 Market Sales by Geography (USD MN)
  • 41 - 50 Market Sales by Geography (USD MN)
  • 51 - 60 Market Sales by Geography (USD MN)
  • >60 Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Dermatology Clinics Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Aesthetic Injectables Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Aesthetic Injectables Report
  • Market Research Process
  • Market Research Methodology
  • Global Aesthetic Injectables Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Gender
  • Market Attractiveness Analysis by Age Group
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Botulinum Toxin (Botulinum Toxin A, Botulinum Toxin B) Market Sales by Geography (USD MN)
  • Dermal Fillers (Product (Hyaluronic Acid, Calcium Hydroxyapatite, Poly-L-Lactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Collagen, Fat Fillers, Other Dermal Fillers), Application (Face Lift, Facial Correction, Wrinkles Reduction, Acne Scar, Lipoatrophy, Lip Enhancement, Hip Augmentation, Breast Enhancement, Hand Rejuvenation, Penis Enlargement, Blepharoplasty, Neck & Chin Lift, Other)) Market Sales by Geography (USD MN)
  • Global Market Analysis by Gender (USD MN)
  • Female Market Sales by Geography (USD MN)
  • Male Market Sales by Geography (USD MN)
  • Global Market Analysis by Age Group (USD MN)
  • 15 - 30 Market Sales by Geography (USD MN)
  • 31 - 40 Market Sales by Geography (USD MN)
  • 41 - 50 Market Sales by Geography (USD MN)
  • 51 - 60 Market Sales by Geography (USD MN)
  • >60 Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Dermatology Clinics Market Sales by Geography (USD MN)
  • Other Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.